Literature DB >> 30472375

Insight into long noncoding competing endogenous RNA networks in hepatic fibrosis: The potential implications for mechanism and therapy.

Ben-Sheng Dong1, Miao-Juan Shi1, Shi-Bing Su1, Hui Zhang2.   

Abstract

Mounting evidence has shown that long noncoding RNAs (lncRNAs) can function as competing endogenous RNAs (ceRNAs) in distinct physiological and pathological states. The activation of hepatic stellate cells (HSCs) is a critical event in the development of hepatic fibrosis (HF). LncRNAs have recently been revealed to be involved in HSC activation as ceRNAs. CeRNA analysis tremendously expands the functional information of proteins, DNA and coding and noncoding RNA. In addition, many validated ceRNA networks, including the traditional ceRNA/mRNA/miRNA, participate in the initiation and progress of HF, and additional work is needed in elucidating the potential of ceRNAs in precancer diagnosis, prognosis and providing new therapeutic methods for HF reversion.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatic fibrosis; Network; RNA; ceRNA; lncRNA; miRNA

Mesh:

Substances:

Year:  2018        PMID: 30472375     DOI: 10.1016/j.gene.2018.11.063

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

1.  Long noncoding RNA RHPN1-AS1 exerts pro-oncogenic actions in osteosarcoma by functioning as a molecular sponge of miR-506 to positively regulate SNAI2 expression.

Authors:  Limin Wang; Yanbing Liu
Journal:  Cell Cycle       Date:  2020-05-13       Impact factor: 4.534

2.  Genome-wide identification of chicken bursae of Fabricius miRNAs in response to very virulent infectious bursal disease virus.

Authors:  Xuewei Huang; Yue Li; Xiaona Wang; Junyan Zhang; Li Wang; Han Zhou; Yanping Jiang; Wen Cui; Xinyuan Qiao; Yijing Li; Lijie Tang
Journal:  Arch Virol       Date:  2022-06-25       Impact factor: 2.685

3.  Long Intergenic Non-Coding RNA LINC00922 Aggravates the Malignant Phenotype of Breast Cancer by Regulating the microRNA-424-5p/BDNF Axis.

Authors:  Xin Yue; Zhuo Wang
Journal:  Cancer Manag Res       Date:  2020-08-21       Impact factor: 3.989

4.  LncRNA Neat1 expedites the progression of liver fibrosis in mice through targeting miR-148a-3p and miR-22-3p to upregulate Cyth3.

Authors:  Wei Huang; Feizhou Huang; Rui Zhang; Hongwu Luo
Journal:  Cell Cycle       Date:  2021-02-08       Impact factor: 4.534

5.  Long Noncoding RNA LINC00173 Promotes the Malignancy of Melanoma by Promoting the Expression of IRS4 Through Competitive Binding to microRNA-493.

Authors:  Fan Yang; Pengzhen Lei; Weihui Zeng; Jianwu Gao; Na Wu
Journal:  Cancer Manag Res       Date:  2020-05-05       Impact factor: 3.989

6.  Transcriptomic analysis of the mechanisms of alleviating renal interstitial fibrosis using the traditional Chinese medicine Kangxianling in a rat model.

Authors:  Yufeng Jiang; Yaohan Zhu; Timing Zhen; Jie Li; Kaichen Xing; Liqun He; Sibo Zhu
Journal:  Sci Rep       Date:  2020-06-30       Impact factor: 4.379

7.  Long Noncoding RNA DLGAP1-AS1 Promotes the Aggressive Behavior of Gastric Cancer by Acting as a ceRNA for microRNA-628-5p and Raising Astrocyte Elevated Gene 1 Expression.

Authors:  Jiying Deng; Qin Zhang; Lianwei Lu; Chunxia Fan
Journal:  Cancer Manag Res       Date:  2020-04-29       Impact factor: 3.989

8.  mRNA and lncRNA expression profiles of liver tissues in children with biliary atresia.

Authors:  Wenyan Wu; Weifang Wu; Yongqin Ye; Tao Li; Bin Wang
Journal:  Exp Ther Med       Date:  2022-08-22       Impact factor: 2.751

9.  Long intergenic non‑coding RNA LINC01232 contributes to esophageal squamous cell carcinoma progression by sequestering microRNA‑654‑3p and consequently promoting hepatoma‑derived growth factor expression.

Authors:  Meihua Zhao; Haishan Cui; Baisui Zhao; Mei Li; Haiqing Man
Journal:  Int J Mol Med       Date:  2020-10-09       Impact factor: 4.101

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.